[28-20-am] Pharmacotherapy (Oncology)

2:15 PM - 2:27 PM JST(5:15 AM - 5:27 AM UTC)

[28-20-pm06S] Establishing novel molecular-targeted therapy based on the tumor suppressor gene CYLD to overcome cross-resistance between chemotherapy and radiotherapy

○Kou Yonemaru¹, Naoki Suenaga^1,2, Ayumi Kanemaru^1,3, Hideyuki Saito^1,4, Hirofumi Jono^1,4 (1. Department of Clinical Pharmaceutical Sciences, Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Gofuku Pharm., 3. Clinical Research, Innovation and Education Center, Tohoku Univ. Hospital, 4. Department of Pharmacy, Kumamoto Univ. Hospital)